NASDAQ:SRRK Scholar Rock (SRRK) Stock Price, News & Analysis $31.40 -3.22 (-9.30%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$32.22 +0.83 (+2.63%) As of 08:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Scholar Rock Stock (NASDAQ:SRRK) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Scholar Rock alerts:Sign Up Key Stats Today's Range$30.73▼$35.1050-Day Range$29.13▼$42.8652-Week Range$6.76▼$46.98Volume3.46 million shsAverage Volume1.47 million shsMarket Capitalization$2.98 billionP/E RatioN/ADividend YieldN/APrice Target$45.14Consensus RatingBuy Company Overview Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. Read More Scholar Rock Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks91st Percentile Overall ScoreSRRK MarketRank™: Scholar Rock scored higher than 91% of companies evaluated by MarketBeat, and ranked 128th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.6 / 5Analyst RatingBuy Consensus RatingScholar Rock has received a consensus rating of Buy. The company's average rating score is 3.22, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageScholar Rock has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Scholar Rock's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Scholar Rock are expected to grow in the coming year, from ($2.42) to ($2.12) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Scholar Rock is -10.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Scholar Rock is -10.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioScholar Rock has a P/B Ratio of 7.97. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted14.92% of the outstanding shares of Scholar Rock have been sold short.Short Interest Ratio / Days to CoverScholar Rock has a short interest ratio ("days to cover") of 11.2, which indicates bearish sentiment.Change versus previous monthShort interest in Scholar Rock has recently decreased by 0.28%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldScholar Rock does not currently pay a dividend.Dividend GrowthScholar Rock does not have a long track record of dividend growth. Sustainability and ESG4.4 / 5Environmental Score-1.09 Percentage of Shares Shorted14.92% of the outstanding shares of Scholar Rock have been sold short.Short Interest Ratio / Days to CoverScholar Rock has a short interest ratio ("days to cover") of 11.2, which indicates bearish sentiment.Change versus previous monthShort interest in Scholar Rock has recently decreased by 0.28%, indicating that investor sentiment is improving. News and Social Media2.4 / 5News Sentiment0.27 News SentimentScholar Rock has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Scholar Rock this week, compared to 7 articles on an average week.Search InterestOnly 7 people have searched for SRRK on MarketBeat in the last 30 days. This is a decrease of -22% compared to the previous 30 days.MarketBeat Follows18 people have added Scholar Rock to their MarketBeat watchlist in the last 30 days. This is an increase of 260% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Scholar Rock insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,101,811.00 in company stock.Percentage Held by Insiders13.30% of the stock of Scholar Rock is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions91.08% of the stock of Scholar Rock is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Scholar Rock's insider trading history. Receive SRRK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Scholar Rock and its competitors with MarketBeat's FREE daily newsletter. Email Address SRRK Stock News HeadlinesJeffrey S. Flier Sells 11,136 Shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) StockJuly 19, 2025 | insidertrades.comScholar Rock (NASDAQ:SRRK) Trading Down 10.2% on Disappointing EarningsAugust 8 at 3:09 AM | americanbankingnews.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.August 8 at 2:00 AM | Brownstone Research (Ad)Scholar Rock (NASDAQ:SRRK) Shares Gap Down on Disappointing EarningsAugust 8 at 2:45 AM | americanbankingnews.comScholar Rock outlines Q3 2025 U.S. apitegromab launch plans amid regulatory progress and global expansion focusAugust 7 at 3:32 AM | msn.comScholar Rock Holding Corporation (SRRK) Q2 2025 Earnings Call TranscriptAugust 6 at 12:01 AM | seekingalpha.comWhy Scholar Rock Stock Wilted on WednesdayAugust 6 at 6:13 PM | fool.comScholar Rock Reports Second Quarter 2025 Financial Results and Highlights Business ProgressAugust 6 at 7:29 AM | businesswire.comSee More Headlines SRRK Stock Analysis - Frequently Asked Questions How have SRRK shares performed this year? Scholar Rock's stock was trading at $43.22 on January 1st, 2025. Since then, SRRK stock has decreased by 27.3% and is now trading at $31.40. How were Scholar Rock's earnings last quarter? Scholar Rock Holding Corporation (NASDAQ:SRRK) posted its quarterly earnings data on Wednesday, August, 6th. The company reported ($0.98) earnings per share for the quarter, missing analysts' consensus estimates of ($0.66) by $0.32. Read the conference call transcript. When did Scholar Rock IPO? Scholar Rock (SRRK) raised $76 million in an IPO on Thursday, May 24th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. Jefferies, Cowen and BMO Capital Markets served as the underwriters for the IPO and Wedbush PacGrow was co-manager. Who are Scholar Rock's major shareholders? Scholar Rock's top institutional investors include Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. (0.81%), Jennison Associates LLC (0.39%), TD Asset Management Inc (0.35%) and Bank of New York Mellon Corp (0.23%). Insiders that own company stock include Public Equities LP Invus, Samsara Biocapital Gp, Llc, Srinivas Akkaraju, Akshay Vaishnaw, Jay T Backstrom, Junlin Ho, Caryn Parlavecchio, Mo Qatanani, Edward H Myles, Tracey Sacco, Jing L Marantz, Michael Gilman, Katie Peng, Jeffrey S Flier, Kristina Burow and Joshua Reed. View institutional ownership trends. How do I buy shares of Scholar Rock? Shares of SRRK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Scholar Rock own? Based on aggregate information from My MarketBeat watchlists, some other companies that Scholar Rock investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), First Solar (FSLR) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings8/06/2025Today8/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:SRRK CIK1727196 Webwww.scholarrock.com Phone(857) 259-3860Fax866-493-4935Employees140Year FoundedN/APrice Target and Rating Average Price Target for Scholar Rock$45.14 High Price Target$53.00 Low Price Target$31.00 Potential Upside/Downside+43.8%Consensus RatingBuy Rating Score (0-4)3.22 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)($2.53) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$246.29 million Net MarginsN/A Pretax MarginN/A Return on Equity-124.59% Return on Assets-89.21% Debt Debt-to-Equity Ratio0.16 Current Ratio10.25 Quick Ratio10.25 Sales & Book Value Annual Sales$33.19 million Price / Sales89.83 Cash FlowN/A Price / Cash FlowN/A Book Value$3.94 per share Price / Book7.97Miscellaneous Outstanding Shares94,950,000Free Float82,318,000Market Cap$2.98 billion OptionableOptionable Beta0.48 Social Links 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:SRRK) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scholar Rock Holding Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Scholar Rock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.